Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cronos Group Inc (CRON.TO)

Cronos Group Inc (CRON.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cronos Group Inc 111 Peter Street Suite 300 Toronto ON M5V 2H1 CAN

https://www.thecronosgroup.com P: 416-504-0004

Description:

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

Key Statistics

Overview:

Market Capitalization, $K 1,300,229
Shares Outstanding, K 381,299
Annual Sales, $ 87,241 K
Annual Net Income, $ -73,963 K
Last Quarter Sales, $ 23,915 K
Last Quarter Net Income, $ -44,790 K
60-Month Beta 1.22
% of Institutional Shareholders 7.87%

Growth:

1-Year Return 38.06%
3-Year Return -66.00%
5-Year Return -84.69%
5-Year Revenue Growth 48.40%

Per-Share Information:

Latest Earnings Date 05/14/24
Earnings Per Share ttm -0.19
EPS Growth vs. Prev Year -59.04%
Dividend Payout Ratio 0.00%

CRON.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -6.59%
Return-on-Assets % -6.29%
Profit Margin % -84.78%
Debt/Equity 0.00
Price/Sales 10.87
Price/Book 0.86
Book Value/Share 3.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar